Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mirati Therapeutics (MRTX)
NASDAQ:MRTX
RESEARCH TOOLSreports
Holding MRTX?
Track your performance easily
MRTX Stock Chart & Stats
Day’s Range$58.54 - $58.99
52-Week Range― - ―
Previous Close$58.8
Volume20.99M
Average Volume (3M)N/A
Market Cap
$4.12B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$58.67Price Target Upside-0.05% Downside
Rating ConsensusHold
Number of Analyst Covering5
Mirati Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MRTX FAQ
What was Mirati Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Mirati Therapeutics’s market cap?
Currently, no data Available
When is Mirati Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Mirati Therapeutics’s earnings last quarter?
Currently, no data Available
Is Mirati Therapeutics overvalued?
According to Wall Street analysts Mirati Therapeutics’s price is currently Overvalued.
Does Mirati Therapeutics pay dividends?
Mirati Therapeutics does not currently pay dividends.
What is Mirati Therapeutics’s EPS estimate?
Mirati Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mirati Therapeutics have?
Currently, no data Available
What happened to Mirati Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Mirati Therapeutics?
Among the largest hedge funds holding Mirati Therapeutics’s share is Baker Bros Advisors LP. It holds Mirati Therapeutics’s shares valued at 61M.
---
Mirati Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$58.67 (-0.05% Downside)
$58.67 (-0.05% Downside)
Blogger Sentiment
Bullish
MRTX Sentiment 88%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 44.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $877.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.5%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Company Description
Mirati Therapeutics
Mirati Therapeutics, Inc. is a clinical-stage oncology company. The firm engages in developing a pipeline of oncology products to treat genetic, immunological and epigenetic drivers of cancer in subsets of cancer patients. Its clinical pipeline consists of glesatinib, sitravatinib and mocetinostat. The company was founded on December 13, 1995 and is headquartered in San Diego, CA.
---
MRTX Stock 12 Month Forecast
Average Price Target
$58.67
▼(-0.05% Downside)
Technical Analysis
Best Analysts Covering MRTX
1 Year
1 Year Success Rate
11/16 ratings generated profit
1 Year Average Return
+40.13%
reiterated a buy rating a year ago
Copying Jay Olson's trades and holding each position for 1 Year would result in 68.75% of your transactions generating a profit, with an average return of +40.13% per trade.
---